Description

Dehydro Clindamycin is a key pharmaceutical intermediate and a derivative of the lincosamide antibiotic clindamycin. This compound is of significant importance in the research and development of novel antibacterial agents and serves as a critical building block for further chemical synthesis. It is primarily utilized by pharmaceutical R&D laboratories, API manufacturers, and fine chemical synthesis specialists seeking high-purity intermediates for advanced therapeutic development.

Application

• Pharmaceutical Intermediate: Serves as a crucial precursor in the synthesis of novel clindamycin analogs and other lincosamide antibiotics.
• Antibacterial Research: Used as a reference standard and active moiety in microbiological and pharmacological studies to investigate structure-activity relationships.
• API Manufacturing: Employed in the controlled production processes for active pharmaceutical ingredients targeting anaerobic and Gram-positive bacterial infections.
• Chemical Synthesis: Acts as a specialized starting material or intermediate for organic chemists developing new compounds with potential therapeutic value.
• Analytical Standard: Provides a high-purity standard for quality control and analytical method development (e.g., HPLC, LC-MS) in pharmaceutical laboratories.

Basic Information

Product Name	Dehydro Clindamycin
CAS No.	909032-77-5
Molecular Formula	C18H33ClN2O5S
Molecular Weight	424.98 g/mol
Synonyms	2-Deoxy-2-[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-L-threo-α-D-galacto-octopyranoside 7-chloro-4,7-dideoxy-; 7(S)-Chloro-7-deoxylincomycin; Clindamycin Impurity; Dehydroclindamycin; (2S,4R)-N-[(1S,2S)-2-Chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2H-pyran-2-yl]propyl]-1-methyl-4-propyl-2-pyrrolidinecarboxamide
EINECS	Contact for details

Quality Control

Our Dehydro Clindamycin is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via IR and NMR spectroscopy, to ensure it meets exacting standards for pharmaceutical intermediate use. A comprehensive Certificate of Analysis (COA) detailing all test results is provided with every shipment to guarantee traceability and compliance.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed in a dry environment to prevent moisture absorption, which may affect stability and handling properties.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time corresponds to reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 1.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.